Cuvitru

Cuvitru is a subcutaneous immunoglobulin therapy designed to support immune function. Learn about its uses, effects, and precautions for managing immune-related conditions.

Cuvitru is primarily used to treat primary immune deficiencies, providing essential antibodies to support the immune system. It may also be used for other immune-related conditions as determined by a healthcare provider. Cuvitru is administered subcutaneously, offering a convenient and effective method of delivery.

Common effects of Cuvitru may include localized reactions at the injection site, such as redness, swelling, or itching. Some individuals may experience mild systemic effects like headache or fatigue. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

Cuvitru should be handled with care, ensuring proper storage and administration techniques. It is important to follow the healthcare provider's instructions for use and to monitor for any adverse reactions. Individuals with a history of severe allergic reactions to immunoglobulin products should use Cuvitru with caution.

Cuvitru may interact with certain medications, including those that affect the immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances should be discussed with a healthcare provider to ensure safe use of Cuvitru.